Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Cell Rep Med
; 5(5): 101586, 2024 May 21.
Article
in En
| MEDLINE
| ID: mdl-38723625
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cell Rep Med
Year:
2024
Document type:
Article